NCT07168122

Brief Summary

The goal of this observational study is to establish the normal reference intervals of salivary cortisol and optimal cut-offs for Cushing's sydrome and adrenal insufficiency.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for all trials

Timeline
20mo left

Started Sep 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Sep 2025Dec 2027

First Submitted

Initial submission to the registry

August 27, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 11, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

September 11, 2025

Status Verified

August 1, 2025

Enrollment Period

1.8 years

First QC Date

August 27, 2025

Last Update Submit

September 4, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Reference intervals of salivary cortisol

    Salivary cortisol levels were evaluated by immunomagnetic-bead-based LC-MS assay and fluorescence immunoassay system to establish its reference intervals according to the 2.5th and 97.5th percentiles.

    8:00, 16:00 and 23:00 on the day of sample collection

  • Optimal cut-off and diagnostic accuracy of salivary cortisol in Cushing's syndrome

    The diagnostic cut-off for each analysis method was defined as either the calculated upper reference interval (97.5th percentile) or the optimal value determined by the Youden index. The sensitivity, specificity and area under curve for Cushing's syndrome was calculated using samples from all available healthy controls and cases.

    23:00 on the day of sample collection

  • Optimal cut-off and diagnostic accuracy of salivary cortisol in adrenal insufficiency

    The diagnostic cut-off for each analysis method was defined as either the calculated lower reference intervals (2.5th percentile) or the optimal value determined by the Youden index. The sensitivity, specificity and area under curve for adrenal insufficiency was calculated using samples from all available healthy controls and cases.

    8:00 on the day of sample collection

  • Comparison of diagnostic accuracy of salivary cortisol in Cushing's syndrome and adrenal insufficiency

    The diagnostic accuracies of the fluorescence immunoassay system and the immunomagnetic-bead-based LC-MS assay were compared by analyzing their areas under the receiver operating characteristic (ROC) curves using DeLong's test for paired statistics.

    8:00 or 23:00 on the day of sample collection

Secondary Outcomes (4)

  • Agreement in assessment of salivary cortisol

    8:00, 16:00 and 23:00 on the day of sample collection

  • Between-groups differences in salivary cortisol of healthy volunteers with different age ranges

    8:00, 16:00 and 23:00 on the day of sample collection

  • Between-groups differences in salivary cortisol of healthy volunteers with different sex

    8:00, 16:00 and 23:00 on the day of sample collection

  • Between-groups differences in salivary cortisol of healthy volunteers with different body mass index ranges

    8:00, 16:00 and 23:00 on the day of sample collection

Study Arms (3)

Heathy Volunteers

120 Healthy Volunteers for the establishment of reference intervals of salivary cortisol

Cushing's sydrome

50 cases diagnosed with Cushing's sydrome

Adrenal insufficiency

50 cases diagnosed with adrenal insufficiency

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The participants are enrolled from Shanghai Sixth People's Hospital, Shanghai.

You may qualify if:

  • Age ≥ 18 and ≤ 60 years old;
  • Body mass index (BMI) ≥ 18.5 and ≤ 24.9 kg\*m\^-2;
  • No previous history of chronic diseases such as hyperglycemia, hypertension, dyslipidemia, coronary heart disease and stroke;
  • Normal glucose regulation, defined as: fasting blood-glucose \< 5.6 mmol/L, 2-hour blood-glucose after glucose load \< 7.8 mmol/L, and glycated hemoglobin (HbA1c) \< 5.7%.

You may not qualify if:

  • Liver or kidney dysfunction, alanine aminotransferase (ALT) or aspartate aminotransferase (AST) or direct bilirubin higher than 1.5 times the upper limit of normal, or serum creatinine \>115 μmol/L;
  • Pregnancy or lactation women, or people with cancer or mental illness;
  • Factors affecting cortisol levels, including hypothalamus-pituitary-adrenal axis disease, autoimmune disease (systemic lupus erythematosus, rheumatoid arthritis, etc.), diagnosed mental disease, Alzheimer's disease, alcoholism (alcohol \> 60 g/d for male, \>40 g/d for women) and corticosteroid therapy in the past 3 months (females with contraceptives or estrogen);
  • Factors affecting saliva collection, such as serious oral problems (oral ulcers, gingival bleeding);
  • Night shift workers, who are awake from 11:00 PM to 7:00 AM;
  • Acute infection (body temperature ≥ 37.3 ℃ or C-reactive protein \> 50 mg/L).
  • Cases:
  • Aged 18 to 80 years old;
  • Patients with suspected Cushing's syndrome or adrenal insufficiency.
  • Corticosteroid therapy within the last 6 weeks;
  • Acute infection;
  • Severe oral conditions;
  • Severe liver and kidney dysfunction;
  • Alcoholism, depression, or other psychiatric disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Sixth People's Hospital

Shanghai, Shanghai Municipality, 200233, China

RECRUITING

MeSH Terms

Conditions

Cushing SyndromeAdrenal Insufficiency

Condition Hierarchy (Ancestors)

Adrenocortical HyperfunctionAdrenal Gland DiseasesEndocrine System Diseases

Central Study Contacts

Jian Zhou, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Professor, Chief Physician, Deputy Director

Study Record Dates

First Submitted

August 27, 2025

First Posted

September 11, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

September 11, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations